|Slideshows|December 16, 2019

State of the Specialty survey: Top pain points are revenue drop, prior auth

Declining reimbursement for their work and the burden of prior authorization are nearly universal concerns of U.S. urologists, an exclusive Urology Times survey has found.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe

Related Content

What health policy issues are shaping urology care heading into 2027?

ByCeleste Kirschner, CAE, MHSA

September 2nd 2026

Zachary Feuer, MD, on building a rapid access program for prostate cancer diagnostic evaluation

ByZach Feuer, MD

August 31st 2026

UF urology chiefs reflect on lessons and milestones from residency

ByMiranda Eubank, MD,Trisha U. Nguyen, MD,Jordan Matthews-Smith, MD

August 28th 2026

Davis Viprakasit, MD, FACS, on the growing role of APPs in cystoscopy

ByDavis Viprakasit, MD, FACS

August 25th 2026

CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom

ByJonathan Rubenstein, MD,Mark Painter

August 21st 2026

Latest CME

Video

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Video

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

State of the Specialty survey: Top pain points are revenue drop, prior auth

Related Content

What health policy issues are shaping urology care heading into 2027?

Zachary Feuer, MD, on building a rapid access program for prostate cancer diagnostic evaluation

UF urology chiefs reflect on lessons and milestones from residency

Davis Viprakasit, MD, FACS, on the growing role of APPs in cystoscopy

CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom

Latest CME

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Trending on Urology Times

John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC

Dabogratinib shows early activity in FGFR3-altered LG-IR-NMIBC

AI-generated profiles impersonate female urologists to market ED products online

TRT, GLP-1s, and peptides: How to counsel patients stacking longevity therapies

The critical role of advocacy in urologic oncology